1 September 2001 in Mayo Clinic Proceedings
1 September 2001 in Mayo Clinic Proceedings
1 October 2017 in Pulmonary Pharmacology & Therapeutics
5 April 2018 in Clinical Hypertension
The data on the association of sleep duration and blood pressure in the pediatric age group have been mixed and most studies have focused on weekday sleep duration. The purpose of this study was to compare the weekday and weekend sleep patterns between children and adolescents with newly diagnosed primary hypertension and a normotensive control group. Children and adolescents from a pediatric nephrology clinic, aged 6-18 years with newly diagnosed primary hypertension were compared to an age and sex matched normotensive control group from a general pediatric clinic. The questions about bed time and getting out of bed times from the Pediatric Sleep Questionnaire (PSQ) were used to obtain weekday and weekend bed time, getting out of bed time and sleep duration. The Pediatric Daytime Sleepiness Scale (PDSS) was used to assess subjective sleepiness. In both groups of 60 subjects each, weekday total sleep time was similar. Subjects in both groups went to bed later and woke up later on the weekends. However, in the hypertensive group, weekend getting out of the bed time was earlier (8:52 AM ±93 min vs. 9:36 AM ±88 min, p = 0.013) and weekend catchup sleep was about 40 min less (62.8 ± 85.5 vs. 102.7 ± 84.9, p = 0.035). Hypertensive children perceived less subjective sleepiness (PDSS scores 8.28 ± 4.88 vs. 10.63 ± 5.41, p = 0.007). The p values were calculated after adjusting for body mass index (BMI), race, daytime nap, caffeine use, sleep related breathing disorder (SRBD) scale and periodic limb movement of sleep (PLMS) scale subcomponents of the PSQ. Hypertensive children obtained less weekend catch up sleep and reported less subjective sleepiness compared to the control group. More weekend sleep may potentially mitigate the effect of weekday sleep deprivation on blood pressure.
29 January 2019 in Mini-Reviews in Medicinal Chemistry
Thiazolidine-2,4-dione (TZD) is one of the most frequently encountered heterocyclic rings which has been implicated in design and synthesis of entities for various pathogenic conditions including cancer. Since its discovery various substitutions at 5th position have been carried out and reviewed. Various substitutions at 5th position have led to generation of glitazones, whose target peroxisome proliferating activated receptor γ (PPARγ) was found decade after their discovery. Acidic hydrogen (-NH) of TZD is a prime pharmacophoric requirement for the activation of PPARγ. However, advanced in-silico techniques have helped to design compounds bearing substitutions at both methylene and –NH group of TZD, targeting range of enzymes involved in various pathological conditions viz., diabetes, hyperlipidemia, infectious disease, inflammation and cancer. The promising activities shown by methylene and N-substituted TZDs in above mentioned therapeutic areas, prompted us to collate the information which would help researchers to alter the structure of existing ligands and to design new TZD derivatives with better safety and efficacy profiles.
26 July 2018 in Indian Journal of Child Health
Background: Intravenous therapy is a major component in the health care and appropriate research-based knowledge is essential to ensure positive patient outcomes. Objective: The objective of the study was to study the use of Central Venous Access Devices (CVADs) and their complications in neonates in routine practice. Methods: A prospective observational study was conducted at a tertiary care neonatal intensive care unit (NICU) on 40 newborns. CVADs were inserted in neonates, who had been anticipated to have intravenous access for >7 days. CVADs used in the study included Peripherally Inserted Central Catheters (PICCs) and umbilical venous catheters. CVADs were inserted under strict aseptic precautions as per international guidelines, and maintenance protocols followed. Monitoring for complications was done daily. Central Line Associated Blood Stream Infection (CLABSI) was established by a combination of suggestive clinical signs and blood culture reports as per Centre for Disease Control and prevention definition. Results: Extremely low birth weight neonates contributed 40% of the patients. PICC insertions formed the 85% of the devices used. Basilic vein was the preferred site of the insertion in almost one-half of the patients. 80% of the PICCs in neonates were used to administer total parenteral nutrition. CLABSI was the most common complication occurring at a rate of 7.5/1000 catheter days. Other complications were occlusion, suspected infection, accidental displacement, and thromboembolism. Conclusion: Central venous catheterization is a safe and efficient procedure with minimal complication in neonates. This study emphasizes its use whenever prolonged intravenous access requirement is expected.